| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/01/2004 | US20040126832 Method for determining the concentration of blood glucose |
| 07/01/2004 | US20040126831 Functionalization of immobilized proteins |
| 07/01/2004 | US20040126828 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 07/01/2004 | US20040126825 Using a compounds ability to decrease integrin activation as a diagnostic tool for the identification of antagonistic modulators of neovascularizaton; antitumor/antiproliferative agents |
| 07/01/2004 | US20040126823 Identifying oncogenic kinase modulators which ca n be used in the prevention and treatment inflammation an d cell proliferative disorders |
| 07/01/2004 | US20040126821 Measuring reaction products of non reducing sugars and amino acid groups and using them as tools to diagnose nervous system disorders |
| 07/01/2004 | US20040126820 Using nanoparticles to identify and/or sequence biomolecules; forensic analysis; medical diagnostics |
| 07/01/2004 | US20040126818 Detecting receptor oligomerization |
| 07/01/2004 | US20040126817 Identifying modulators of cell surface channel proteins; prevention and treatment of cell proliferative, skin and hearing disorders |
| 07/01/2004 | US20040126815 Process for producing activated thrombin-activatable fibrinolysis inhibitor |
| 07/01/2004 | US20040126810 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 07/01/2004 | US20040126807 Isolated nucleic acids; polypeptides showing higher expression on cancer cells |
| 07/01/2004 | US20040126806 Methods and compositions for multiplex amplification of nucleic acids |
| 07/01/2004 | US20040126804 Quantitative, accurate, rapid; does not require selecting representative genes to draw phylogenetic tree |
| 07/01/2004 | US20040126803 Method for profiling and identifying persons by using data samples |
| 07/01/2004 | US20040126802 Nanotube-based microarrays |
| 07/01/2004 | US20040126801 Novel polynucleotides and encoded polypeptides |
| 07/01/2004 | US20040126800 Regulatory single nucleotide polymorphisms and methods therefor |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126798 Reverse transcription synthesis of complementary cDNAs while using actinomycin inhibition of second strand; hybridizing with nucleic acid probe array |
| 07/01/2004 | US20040126797 Uniform reaction using vibration and microbead immobilization; short reaction time, easy processing and postmanipulation; polymerase chain reaction, hybridization |
| 07/01/2004 | US20040126796 Extraction of DNA from biological samples |
| 07/01/2004 | US20040126795 Genetic markers associated with scrotal hernias in pigs |
| 07/01/2004 | US20040126794 Determining risk of type 1 diabetes; prognosis based on presence of class I HLA allele in nucleic acid sample; kits |
| 07/01/2004 | US20040126792 Inhibiting ribosome peptide synthesis; high throughput screening for peptidyl transferase modulators; kits |
| 07/01/2004 | US20040126790 Long nucleic acid sequencing; rapid, automated, simple; unlabeled; microfluidic device; exonuclease releasing |
| 07/01/2004 | US20040126789 Compositions and methods for synthesizing nucleic acids |
| 07/01/2004 | US20040126788 Assessing cell tumorigenicity; detecting mRNA transcription; kits |
| 07/01/2004 | US20040126787 Four groups of SCN5A variants most common in humans; tools to study mutations and design or identify new diagnostic and treatment strategies |
| 07/01/2004 | US20040126786 Determining individual stress factor impact; detecting presence of long alleles |
| 07/01/2004 | US20040126782 System and method for SNP genotype clustering |
| 07/01/2004 | US20040126780 Use of optical diffraction elements in detection methods |
| 07/01/2004 | US20040126778 Isolation of dna molecules |
| 07/01/2004 | US20040126775 Detection of survivin in the biological fluids of cancer patients |
| 07/01/2004 | US20040126774 Correction of factor VIII genetic defects using spliceosome mediated RNA trans splicing |
| 07/01/2004 | US20040126772 Mass spectroscopy analysis with resistance to signal intensity dropoff using alpha phosphorothioate ribonucleotides having 2'-electronegative substituents; kits |
| 07/01/2004 | US20040126771 PRNA chimera |
| 07/01/2004 | US20040126770 Rolling circle amplification of RNA |
| 07/01/2004 | US20040126768 Selection procedure for identifying transgenic cells, embryos, and plants without the use of antibiotics |
| 07/01/2004 | US20040126767 Method and system for disease detection using marker combinations |
| 07/01/2004 | US20040126766 Breakaway seal for processing a subarray of an array |
| 07/01/2004 | US20040126765 Method and compositions for sequencing nucleic acid molecules |
| 07/01/2004 | US20040126764 replication of genomic samples using few primers so that strands are displaced from the nucleic acid molecules in the sample by another replicated strand; multiple displacement amplification (MDA) |
| 07/01/2004 | US20040126763 Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing |
| 07/01/2004 | US20040126762 for drug screening lymphoma, leukemia, and carcinoma agents; monoclonal and polyclonal antibodies; ca proteins; microarrays; solid phase synthesis; kits |
| 07/01/2004 | US20040126761 Modulation of alpha-methylacyl-CoA racemase expression |
| 07/01/2004 | US20040126760 Novel compositions and methods for carrying out multple pcr reactions on a single sample |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126757 Method and apparatus for synthesis of arrays of DNA probes |
| 07/01/2004 | US20040126756 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 07/01/2004 | US20040126755 Gene expression based method for distinguishing metastatic from non-metastatic forms of a tumor, and use in designing therapeutic drugs |
| 07/01/2004 | US20040126752 High RNA binding affinity to complementary nucleic acids and are base and acid stable; treatment of cancer, viral infections |
| 07/01/2004 | US20040126391 Meningococcal antigens |
| 07/01/2004 | US20040126388 Measurement genome reproduction of virus; linked to reproter compound; high speed screening for Hepatitis virus |
| 07/01/2004 | US20040126387 for rapid, sensitive, and specific screening and serotyping tools for quantitative and qualitative epidemiological infectious study |
| 07/01/2004 | US20040126365 Method, system and computer program product for technical management and biocontrol of disease in animal production systems |
| 07/01/2004 | US20040126359 Modulate lymphocyte activation; cell proliferation; apoptosis; signal transduction |
| 07/01/2004 | US20040126319 Screening effect of test agent; forming image; measurement; calibration; quantitative analysis |
| 07/01/2004 | DE202004006282U1 Vorrichtung für die Empfindlichkeitsprüfung bakterieller Infektionserreger und Impfstämme des Geflügels Device for susceptibility testing of bacterial pathogens and vaccine strains in poultry |
| 07/01/2004 | DE19950953B4 Verfahren zur Herstellung lentiviraler Partikel A process for producing lentiviral particles |
| 07/01/2004 | DE10361928A1 Analyzing the condition of the uterine mucosa, useful for assessing endometrial receptivity or diagnosing uterine tumor, based on measuring expression of specific beta subunits of chorionic gonadotrophin |
| 07/01/2004 | DE10261480A1 Using random oligomers as reference standards in competitive hybridization of multiple samples, particularly microarray tests, to normalize for experimental variations |
| 07/01/2004 | DE10259820A1 DNA-Chip mit Mikroarray aus Mikroelektrodensystemen DNA chip microarray of microelectrode systems |
| 07/01/2004 | DE10014685B4 Verfahren zur Identifizierung von zellspezifischen Zielstrukturen A method for identifying cell-specific target structures |
| 07/01/2004 | CA2510179A1 A method for improving protein production |
| 07/01/2004 | CA2510150A1 Compounds and methods for detection of carcinomas and their precursor lesions |
| 07/01/2004 | CA2509832A1 Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor |
| 07/01/2004 | CA2509831A1 Method of diagnosis of obesity |
| 07/01/2004 | CA2509607A1 Cytochrome c acetylation |
| 07/01/2004 | CA2509520A1 Identification of oligonucleotides for the capture, detection and quantitation of west nile virus |
| 07/01/2004 | CA2509367A1 Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection |
| 07/01/2004 | CA2509333A1 Method for generating a genetically modified organism for screening active substances |
| 07/01/2004 | CA2506217A1 New expression system from rhodococcus |
| 06/30/2004 | EP1434054A1 Biosensor for determining low density cholesterol |
| 06/30/2004 | EP1433859A1 Method of determining target protein of drug |
| 06/30/2004 | EP1433848A1 Novel serine protease inhibitory protein mt0039 |
| 06/30/2004 | EP1433792A2 Human receptor proteins, related reagents and methods |
| 06/30/2004 | EP1432993A2 In vitro model for priocidal activity |
| 06/30/2004 | EP1432991A1 Identification and isolation of somatic stem cells and uses thereof |
| 06/30/2004 | EP1432989A1 Randomly ordered arrays and methods of making and using |
| 06/30/2004 | EP1432987A2 Particle based homogeneous assays using capillary electrophoresis with laser-induced fluorescence detection |
| 06/30/2004 | EP1432986A1 A screening system for identifying drug-drug interactions and methods of use thereof |
| 06/30/2004 | EP1432984A1 Algorithm for estimating the outcome of inflammation following injury or infection |
| 06/30/2004 | EP1432983A1 Method for identifying polymorphic markers in a population |
| 06/30/2004 | EP1432833A2 Apparatus and methods for monitoring the status of a metabolically active cell |
| 06/30/2004 | EP1432832A2 Detection and quantification of human herpes viruses |
| 06/30/2004 | EP1432831A2 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays |
| 06/30/2004 | EP1432830A1 Method for isolating dna from biological samples |
| 06/30/2004 | EP1432829A2 Detection of polynucleotide hybridization |
| 06/30/2004 | EP1432828A2 Method for the determination of cytosine methylation in cpg islands |
| 06/30/2004 | EP1432827A2 Method for detecting dna methylation using labelled s-adenosylmethionine analogs |
| 06/30/2004 | EP1432826A2 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 06/30/2004 | EP1432825A1 Affinity tag modified particles |
| 06/30/2004 | EP1432824A2 Compositions and methods relating to prostate specific genes and proteins |
| 06/30/2004 | EP1432823A2 Mitochondrial biology expression arrays |
| 06/30/2004 | EP1432820A2 Expression profiling |
| 06/30/2004 | EP1432819A2 Method for determining cell cycle position |
| 06/30/2004 | EP1432818A1 Nucleic acid archiving |
| 06/30/2004 | EP1432817A1 Methods and arrays for detecting biological molecules |
| 06/30/2004 | EP1432816A2 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances |